Free Trial

CNBX Pharmaceuticals (CNBX) Short Interest Ratio & Short Volume

CNBX Pharmaceuticals logo
$0.0009 0.00 (-10.00%)
As of 06/12/2025 03:59 PM Eastern

CNBX Pharmaceuticals Short Interest Data

CNBX Pharmaceuticals (CNBX) has a short interest of 54,100 shares. This marks a -68.91% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 1.68 million shares to cover all short positions.

Current Short Interest
54,100 shares
Previous Short Interest
174,000 shares
Change Vs. Previous Month
-68.91%
Dollar Volume Sold Short
$75.74
Short Interest Ratio
0.0 Days to Cover
Last Record Date
May 31, 2025
Today's Trading Volume
12,231,661 shares
Average Trading Volume
1,682,753 shares
Today's Volume Vs. Average
727%
Short Selling CNBX Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for CNBX Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CNBX Short Interest Over Time

CNBX Days to Cover Over Time

CNBX Percentage of Float Shorted Over Time

CNBX Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/31/202554,100 shares $75.74 -68.9%N/A0 $0.00
5/15/2025174,000 shares $243.60 No ChangeN/A0 $0.00
4/15/2025116,200 shares $1.10 thousand No ChangeN/A1 $0.01
2/28/20253,800 shares $28.88 +3,700.0%N/A0 $0.01
2/15/2025100 shares $1.00 -99.9%N/A0 $0.01
1/31/202589,100 shares $953.37 No ChangeN/A0.4 $0.01
12/15/202419,100 shares $171.90 -87.6%N/A0.1 $0.01
11/30/2024154,200 shares $1.16 thousand -19.0%N/A4.4 $0.01
11/15/2024190,400 shares $1.54 thousand +2,438.7%N/A0.8 $0.01
10/31/20247,500 shares $59.25 -11.8%N/A0 $0.01
10/15/20248,500 shares $79.90 No ChangeN/A0 $0.01
9/30/20248,500 shares $59.50 No ChangeN/A0.1 $0.01
7/31/2024100 shares $0.67 -50.0%N/A0 $0.01
7/15/2024200 shares $1.28 -83.3%N/A0 $0.01
6/30/20241,200 shares $6.84 -70.7%N/A0 $0.01
6/15/20244,100 shares $38.54 -72.9%N/A0 $0.01
5/31/202415,100 shares $135.90 No ChangeN/A0 $0.01
4/30/20242,200 shares $32.56 No ChangeN/A0 $0.01
3/31/2024300 shares $4.77 +200.0%N/A0 $0.02
3/15/2024100 shares $1.60 No ChangeN/A0 $0.02
2/15/20241,500 shares $18.75 -92.5%N/A0 $0.01
1/15/202423,000 shares $370.30 +11,400.0%N/A0 $0.02
12/31/2023200 shares $2.84 No ChangeN/A0 $0.01
11/15/202330,100 shares $376.25 +9,933.3%N/A0.1 $0.01
10/31/2023300 shares $5.10 No ChangeN/A0 $0.02
9/30/202335,000 shares $612.50 No ChangeN/A0 $0.02
8/31/2023100 shares $1.69 -99.2%N/A0 $0.02
8/15/202312,100 shares $177.87 +105.1%N/A0 $0.01
7/31/20235,900 shares $91.45 -83.8%N/A0 $0.02
7/15/202336,400 shares $436.80 No ChangeN/A0.1 $0.01
6/15/20239,200 shares $180.32 -39.1%N/A0 $0.02
5/31/202315,100 shares $312.57 +3,675.0%N/A0 $0.02
5/15/2023400 shares $5.84 No ChangeN/A0 $0.01
3/31/20231,200 shares $44.40 -86.2%N/A0 $0.04
3/15/20238,700 shares $717.75 +1,350.0%N/A0 $0.08
2/28/2023600 shares $58.50 No ChangeN/A0 $0.10
1/31/2023300 shares $81.00 +200.0%N/A0 $0.27
1/15/2023100 shares $95.00 No ChangeN/A0 $0.95
12/15/2022100 shares $400.00 -80.0%N/A0.2 $4.00
11/30/2022500 shares $1.98 thousand +66.7%N/A1 $3.96
The End of Elon Musk…? (Ad)

The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.

Click here to see why the "End of Elon" crowd is about to be wrong again.
11/15/2022300 shares $1.11 thousand +200.0%N/A0.3 $3.70
10/31/2022100 shares $382.50 No ChangeN/A0.2 $3.83
8/15/2022600 shares $2.40 thousand No ChangeN/A0.7 $4.00
6/30/2022100 shares $354.00 No ChangeN/A0.2 $3.54
6/15/2022100 shares $390.00 No ChangeN/A0.1 $3.90
4/30/20229,700 shares $758.54 -72.8%N/A0.1 $0.08
4/15/202235,600 shares $3.01 thousand -59.7%N/A0.2 $0.08
3/31/202288,300 shares $7.75 thousand +4,805.6%N/A0.3 $0.09
3/15/20221,800 shares $119.16 -83.8%N/A0 $0.07
2/28/202211,100 shares $888.00 No ChangeN/A0.1 $0.08
12/31/202170,900 shares $5.57 thousand No ChangeN/A0.1 $0.08
11/30/20215,800 shares $768.50 +34.9%N/A0 $0.13
11/15/20214,300 shares $580.50 -18.9%N/A0 $0.14
10/29/20215,300 shares $795.00 +657.1%N/A0 $0.15
10/15/2021700 shares $97.86 -88.9%N/A0 $0.14
9/30/20216,300 shares $975.24 +14.6%N/A0 $0.15
9/15/20215,500 shares $869.00 -28.6%N/A0 $0.16
8/31/20217,700 shares $1.31 thousand +250.0%N/A0 $0.17
8/13/20212,200 shares $378.18 -97.4%N/A0 $0.17
7/30/202184,200 shares $14.13 thousand +306.8%N/A0.4 $0.17
7/15/202120,700 shares $3.73 thousand -50.1%N/A0.1 $0.18
6/30/202141,500 shares $7.74 thousand -85.5%N/A0.2 $0.19
6/15/2021286,300 shares $54.40 thousand +24.2%N/A0.7 $0.19
5/28/2021230,600 shares $44.78 thousand +8.6%N/A1 $0.19
5/14/2021212,300 shares $40.76 thousand -49.4%N/A0.6 $0.19
4/30/2021419,400 shares $78.64 thousand +82.2%N/A0.6 $0.19
4/15/2021230,200 shares $51.56 thousand -83.7%N/A0.3 $0.22
3/31/20211,407,900 shares $341.42 thousand +94.4%N/A3.1 $0.24
3/15/2021724,200 shares $287.51 thousand +7.8%N/A1.3 $0.40
2/26/2021672,100 shares $322.61 thousand +2.9%N/A0.7 $0.48
2/12/2021653,000 shares $336.30 thousand -0.2%N/A0.4 $0.52
1/29/2021654,300 shares $189.35 thousand +2.2%N/A1.2 $0.29
1/15/2021526,200 shares $125.24 thousand -11.3%N/A1.1 $0.24
12/31/2020585,000 shares $128.70 thousand +11.2%N/A1.9 $0.22
12/15/2020526,200 shares $141.92 thousand -11.3%N/A1.1 $0.27
11/30/2020593,200 shares $172.03 thousand +0.4%N/A0.5 $0.29
11/15/2020591,100 shares $112.31 thousand +0.8%N/A3.6 $0.19
10/30/2020586,600 shares $105.59 thousand +0.0%N/A2.6 $0.18
10/15/2020586,400 shares $96.76 thousand -0.9%N/A5.5 $0.17
9/30/2020591,800 shares $97.65 thousand -4.2%N/A9.4 $0.17
9/15/2020617,600 shares $110.67 thousand +4.9%N/A3.7 $0.18
8/31/2020588,600 shares $112.42 thousand +0.4%N/A4 $0.19
8/14/2020586,400 shares $113.76 thousand No ChangeN/A4.2 $0.19
7/31/2020586,400 shares $117.34 thousand No ChangeN/A3.1 $0.20
7/15/2020586,400 shares $124.61 thousand 0.0%N/A3.8 $0.21
6/30/2020586,500 shares $139.12 thousand -0.9%N/A2.4 $0.24
6/15/2020591,700 shares $162.24 thousand -0.3%N/A1.4 $0.27

CNBX Short Interest - Frequently Asked Questions

What is CNBX Pharmaceuticals' current short interest?

Short interest is the volume of CNBX Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 31st, investors have sold 54,100 shares of CNBX short. Learn More on CNBX Pharmaceuticals' current short interest.

Is CNBX Pharmaceuticals' short interest increasing or decreasing?

CNBX Pharmaceuticals saw a drop in short interest during the month of May. As of May 31st, there was short interest totaling 54,100 shares, a drop of 68.9% from the previous total of 174,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does CNBX Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "cannabis" compare to CNBX Pharmaceuticals: Innovative Industrial Properties, Inc. (6.13%), GrowGeneration Corp. (7.44%), Grow Capital, Inc. (0.00%), Trees Co. (0.00%), 22nd Century Group, Inc. (4.61%), Pervasip Corp. (0.00%), Mentor Capital, Inc. (0.01%), and Net Savings Link, Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), Strategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks.

What does it mean to sell short CNBX Pharmaceuticals stock?

Short selling CNBX is an investing strategy that aims to generate trading profit from CNBX Pharmaceuticals as its price is falling. CNBX shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against CNBX Pharmaceuticals?

A short squeeze for CNBX Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CNBX, which in turn drives the price of the stock up even further.

How often is CNBX Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CNBX, twice per month. The most recent reporting period available is May, 31 2025.




This page (OTCMKTS:CNBX) was last updated on 6/13/2025 by MarketBeat.com Staff
From Our Partners